Syngene signs Librela-focused biologics manufacturing agreement with Zoetis
Syngene International Limited has signed a 10-year biologics manufacturing agreement with American animal health company Zoetis for manufacturing the drug substance for Librela (bedinvetmab), a first in class monoclonal antibody used for the treatment of osteoarthritis in dogs. The Indian research, development, and manufacturing services company has been collaborating with Zoetis since 2011. During this […]